Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Desmopressin 200microgram tablets
0605020E0AAAEAE
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 28,994 |
|
Desmopressin 100microgram tablets
0605020E0AAADAD
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 14,103 |
|
Desmopressin 120microgram oral lyophilisates sugar free
0605020E0AABLBL
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 13,411 |
|
Desmopressin 240microgram oral lyophilisates sugar free
0605020E0AABNBN
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 9,727 |
|
Desmopressin 10micrograms/dose nasal spray
0605020E0AAACAC
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 7,351 |
|
Desmopressin 50microgram oral lyophilisates sugar free
0605020E0AABUBU
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 3,206 |
|
Desmopressin 25microgram oral lyophilisates sugar free
0605020E0AABVBV
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 2,273 |
|
Desmopressin 120microgram sublingual tablets sugar free
0605020E0AABYBY
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1,938 |
|
Desmopressin 240microgram sublingual tablets sugar free
0605020E0AACACA
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1,134 |
|
Desmopressin 60microgram oral lyophilisates sugar free
0605020E0AABMBM
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 803 |
|
Desmopressin 360micrograms/ml oral solution sugar free
0605020E0AABXBX
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 637 |
|
Desmopressin 60microgram sublingual tablets sugar free
0605020E0AABZBZ
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 99 |
|
Desmopressin 100micrograms/ml intranasal solution
0605020E0AAABAB
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 69 |
|
Desmopressin 4micrograms/1ml solution for injection ampoules
0605020E0AAAAAA
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 66 |
|
Desmopressin 200micrograms/5ml oral liquid
0605020E0AABDBD
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 33 |
|
Desmopressin 20micrograms/5ml oral liquid
0605020E0AABCBC
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 20 |
|
Desmopressin 2.5micrograms/dose nasal spray
0605020E0AABPBP
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 18 |
|
Desmopressin 10micrograms/ml intranasal solution
0605020E0AAAPAP
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 10 |
|
Desmopressin 10micrograms/5ml oral liquid
0605020E0AABEBE
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1 |
|
Desmopressin 50micrograms/5ml oral liquid
0605020E0AABIBI
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1 |
|
Desmopressin 5micrograms/5ml oral solution
0605020E0AABSBS
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1 |
|
Desmopressin 100micrograms/5ml oral liquid
0605020E0AAAYAY
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 12.5microgram capsules
0605020E0AAALAL
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 150micrograms/dose nasal spray
0605020E0AAASAS
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 15micrograms/1ml inj ampoules
0605020E0AABKBK
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.